Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000381605 | SCV000337344 | likely benign | not specified | 2015-11-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000649028 | SCV000770853 | benign | Niemann-Pick disease, type C1 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001573088 | SCV005889764 | benign | not provided | 2024-12-01 | criteria provided, single submitter | clinical testing | NPC1: BP4, BS1, BS2 |
Laboratory of Diagnostic Genome Analysis, |
RCV001573088 | SCV001798439 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001573088 | SCV001809685 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000381605 | SCV001972867 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000649028 | SCV002095199 | likely benign | Niemann-Pick disease, type C1 | 2019-09-27 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003920080 | SCV004736431 | benign | NPC1-related disorder | 2023-11-15 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |